LakeShore Biopharma Competitors and Similar CompaniesClear all
LakeShore Biopharma's competitors and similar companies include UCB, Genentech, Ipsen and Livzon Pharmaceutical Group.
 LakeShore Biopharma LakeShore Biopharma (湖岸生物, formerly known as Yisheng Biopharma, YS Biopharma, 辽宁依生生物制药有限公司) is a company engaged in the development, production, marketing, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. |  Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | ||
Founding Date | Founding Date 2002 | Founding Date 1928 | Founding Date 1976 | Founding Date 1929 | Founding Date 1985 |
Type | Type Public | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Beijing, CN HQ Gaithersburg, US | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN |
Employees | Employees 773 | Employees 9,052 | Employees 18,077 | Employees 5,358 | Employees 9,067 |
Valuation ($) | Valuation ($) 192.1 m | Valuation ($) 34.3 b | Valuation ($) N/A | Valuation ($) 10.2 b | Valuation ($) 4.2 b |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥615m (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) ¥11.7b (FY, 2025) |
Cost of goods | Cost of goods ¥71.1m (FY, 2025) | Cost of goods €1.4b (FY, 2025) | Cost of goods N/A | Cost of goods €659.1m (FY, 2025) | Cost of goods ¥4.1b (FY, 2025) |
Gross profit | Gross profit ¥543.8m (FY, 2025) | Gross profit €7.2b (FY, 2025) | Gross profit N/A | Gross profit €3.3b (FY, 2025) | Gross profit ¥7.8b (FY, 2025) |
Net income | Net income (¥100m) (FY, 2025) | Net income €1.6b (FY, 2025) | Net income N/A | Net income €445.1m (FY, 2025) | Net income ¥2.4b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View companyGenentech
HQ
South San Francisco, US
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View company